Mirikizumab Uses, Dosage, Side Effects and more
Mirikizumab is under investigation in clinical trial NCT03053622 (A Study of Mirikizumab (LY3074828) Injection in Healthy Participants).
| Attribute | Details |
|---|---|
| Trade Name | Mirikizumab |
| Generic | Mirikizumab |
| Mirikizumab Other Names | Mirikizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
